1. Home
  2. ARQQ vs STXS Comparison

ARQQ vs STXS Comparison

Compare ARQQ & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arqit Quantum Inc.

ARQQ

Arqit Quantum Inc.

HOLD

Current Price

$13.37

Market Cap

220.5M

Sector

Technology

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.88

Market Cap

182.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARQQ
STXS
Founded
2017
1990
Country
United Kingdom
United States
Employees
91
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.5M
182.3M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
ARQQ
STXS
Price
$13.37
$1.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$60.00
$4.00
AVG Volume (30 Days)
335.4K
333.3K
Earning Date
05-21-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$29,346,617.00
Revenue This Year
$381.13
$28.22
Revenue Next Year
$212.00
$30.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.52
$1.74
52 Week High
$62.00
$3.59

Technical Indicators

Market Signals
Indicator
ARQQ
STXS
Relative Strength Index (RSI) 41.95 46.53
Support Level $13.04 $1.75
Resistance Level $17.75 $1.99
Average True Range (ATR) 1.02 0.10
MACD -0.13 0.00
Stochastic Oscillator 14.83 47.92

Price Performance

Historical Comparison
ARQQ
STXS

About ARQQ Arqit Quantum Inc.

Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: